CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy

European Commission decision on marketing authorisation is expected in July 2025.

New treatment of Duchenne muscular dystrophy

Italfarmaco and Medis Announce Exclusive Distribution Agreement for Givinostat in 17 Central and Eastern European Countries including the Baltic States

Givinostat has already received regulatory approval in the US and UK, with an evaluation ongoing by the European Medicines Agency (EMA).

Celebration of Outstanding research achievements

Winners of the 11th International Medis Awards for Medical Research announced

The President of the Republic of Slovenia Nataša Pirc Musar, PhD, was the honorary speaker at the ceremony.

Recognition for Excellence in the Workplace

Medis Wins the Prestigious German Economy Award 2024/25

The company Medis has been awarded the German Economy Award 2024/25 in the category "Excellent Employer".

Award for outstanding achievements in management

Artemis 2024 Award to Maja Strnad Cestar

The award is presented annually by the Association of Managers to managers in Slovenia.

Commercialization of WAYA Biotic D3 drops

New Partnership with Faes Pharma Portugal

We are proud to announce a new partnership with Faes Farma Portugal for the commercialization of WAYA Biotic D3 drops under the brand name Gut4Neo.